Real-World Efficacy of IL-23 Inhibitors in Psoriasis Affecting High-Impact Areas: Indirect Comparison of Tildrakizumab 200 mg, Risankizumab, and Guselkumab—IL PSO (Italian Landscape Psoriasis).
Saved in:
| Title: | Real-World Efficacy of IL-23 Inhibitors in Psoriasis Affecting High-Impact Areas: Indirect Comparison of Tildrakizumab 200 mg, Risankizumab, and Guselkumab—IL PSO (Italian Landscape Psoriasis). |
|---|---|
| Authors: | Trovato, Emanuele1 (AUTHOR), Cartocci, Alessandra1 (AUTHOR), Gaiani, Francesca2 (AUTHOR), Messina, Francesco2 (AUTHOR), Mastorino, Luca3 (AUTHOR), Macagno, Nicole3 (AUTHOR), Carugno, Andrea4 (AUTHOR), Campoli, Marco4 (AUTHOR), Fargnoli, Maria Concetta5 (AUTHOR), Lora, Viviana5 (AUTHOR), Rossi, Agnese6 (AUTHOR), Gioacchini, Helena7 (AUTHOR), Potestio, Luca8 (AUTHOR), D'Agostino, Giovanni Marco7 (AUTHOR), Maurelli, Martina9 (AUTHOR), Girolomoni, Giampiero9 (AUTHOR), Romanelli, Marco10 (AUTHOR), Dini, Valentina10 (AUTHOR), Loconsole, Francesco11 (AUTHOR), Satolli, Francesca12 (AUTHOR) |
| Source: | Dermatology & Therapy. Mar2026, Vol. 16 Issue 3, p1675-1692. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
